C85.97 Non-Hodgkin lymphoma, unspecified, spleen

Name of the Condition

• Common Name: Non-Hodgkin Lymphoma
• Medical Term: Non-Hodgkin lymphoma, unspecified, spleen
• ICD Code: C85.97

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that affect the lymphatic system, part of the immune system. This code is used when the specific subtype of NHL is not clearly defined and the lymphoma is located in the spleen. The lymphatic system helps fight infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections, immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen spleen (abdominal pain or fullness)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal discomfort or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI), blood tests, and biopsy of the spleen or affected lymph nodes. A bone marrow biopsy may also be performed to assess for spread. Pathology reports confirm the presence of lymphoma and help rule out other conditions.

Treatment Options

• Chemotherapy: Uses drugs to destroy cancer cells, often the primary treatment for NHL.
• Radiation therapy: Targets the spleen or affected areas to reduce tumor size.
• Immunotherapy: Boosts the immune system to fight cancer cells.
• Surgery: Splenectomy (removal of the spleen) may be considered in specific cases.
• Targeted therapy: Uses drugs to target specific cancer cell characteristics.

Prognosis and Follow-Up

Prognosis depends on factors like the subtype, stage, and overall health. Regular follow-up appointments monitor for recurrence or complications. Treatment response and long-term survival vary, with some patients achieving remission. Ongoing care may include imaging, blood tests, and symptom management.

Complications

• Splenic rupture or enlargement causing pain
• Infection risk due to impaired immune function
• Anemia or low blood cell counts
• Lymphoma spread to other organs
• Treatment-related side effects (e.g., fatigue, nausea)

Lifestyle & Prevention

• Maintain a balanced diet to support immune health.
• Avoid known carcinogens (e.g., tobacco, excessive alcohol).
• Practice good hygiene to reduce infection risk.
• Stay up-to-date with vaccinations (as recommended by a healthcare provider).
• Manage stress through relaxation techniques or exercise.

When to Seek Professional Help

Seek immediate care for severe abdominal pain, unexplained weight loss, persistent fever, or signs of infection (e.g., chills, high fever). Contact a healthcare provider if symptoms worsen or new ones develop, such as increased fatigue or swelling.

Tips for Medical Coders

Use C85.97 when the medical record specifies non-Hodgkin lymphoma in the spleen without a defined subtype. Ensure documentation supports the spleen as the primary site. If the subtype is known, use a more specific code. Verify that the diagnosis aligns with clinical findings and avoid using this code if the site is unspecified or documented elsewhere.